Extended use of orlistat and sibutramine

被引：0
|
作者：
不详
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2007年 / 82卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：8 / 9
页数：2
相关论文
共 50 条
  • [41] Long-term changes in blood pressure following orlistat and sibutramine treatment: a meta-analysis
    Johansson, K.
    Sundstrom, J.
    Neovius, K.
    Rossner, S.
    Neovius, M.
    OBESITY REVIEWS, 2010, 11 (11) : 777 - 791
  • [42] Sibutramine use in contraindicated conditions continues
    Reactions Weekly, 2007, 1174 (1) : 3 - 3
  • [43] When, for whom and how to use sibutramine?
    Astrup, A
    Toubro, S
    INTERNATIONAL JOURNAL OF OBESITY, 2001, 25 (Suppl 4) : S2 - S7
  • [44] Orlistat use in type 2 diabetes
    Snider, LJ
    Malone, M
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (7-8) : 1210 - 1218
  • [45] Use of sibutramine in obese Hispanic adolescents
    Violante-Ortíz, R
    Del-Rio-Navarro, BE
    Lara-Esqueda, A
    Pérez, P
    Fanghänel, G
    Madero, A
    Berber, A
    ADVANCES IN THERAPY, 2005, 22 (06) : 642 - 649
  • [46] When, for whom and how to use sibutramine
    A Astrup
    S Toubro
    International Journal of Obesity, 2001, 25 : S2 - S7
  • [47] Sibutramine use associated with reversible hepatotoxicity
    Chounta, A
    Tsiodras, S
    Zouridakis, S
    Doumas, M
    Giamarellou, H
    ANNALS OF INTERNAL MEDICINE, 2005, 143 (10) : 763 - 764
  • [48] Use of sibutramine in obese hispanic adolescents
    Rafael Violante-Ortíz
    Blanca Estela Del-Rio-Navarro
    Agustín Lara-Esqueda
    Pedro Pérez
    Guillermo Fanghänel
    Agustín Madero
    Arturo Berber
    Advances in Therapy, 2005, 22 : 642 - 649
  • [49] The use of orlistat in a cardiac rehab program
    Dachman, W
    Erickson, L
    Quan, D
    Baily, M
    Charland, S
    OBESITY RESEARCH, 2003, 11 : A107 - A107
  • [50] Orlistat use and the body mass index
    Goldstein, MR
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (09): : 1055 - 1056
12345